Antibiotic resistance prevalence in routine bloodstream isolates from children's hospitals varies substantially from adult surveillance data in Europe

Pediatric Infectious Disease Journal

Volumn 34, Issue 7, 2015, Pages 734-741

  Bielicki, Julia Anna ^a   Lundin, Rebecca ^b   Sharland, Mike ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Intl Maternal Pediatric Adolescent AIDS Clinical Trials   (Italy)

Author keywords

age differences; antimicrobial resistance; routine data; surveillance

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; CARBAPENEM; CEFTAZIDIME; MACROLIDE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CHILD; DISEASE SURVEILLANCE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GROUPS BY AGE; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; AGE; BACTEREMIA; COMPARATIVE STUDY; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; EUROPE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; EUROPE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE;

EID: 84942835470     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000652     Document Type: Article

References (32)

1. World Health Organization. Antimicrobial Resistance: global report on surveillance. World Health Organization: Geneva, Switzerland; 2014.
2. Cornaglia G, Hryniewicz W, Jarlier V, et al; ESCMID Study Group for Antimicrobial Resistance Surveillance. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect. 2004; 10: 349-383.
3. Giske CG, Cornaglia G, ESCMID Study Group on Antimicrobial Resistance Surveillance (ESGARS). Supranational surveillance of antimicrobial resistance: the legacy of the last decade and proposals for the future. Drug Resist Updat. 2010; 13: 93-98.
4. O'Brien TF, Stelling J,. Integrated multilevel surveillance of the world's infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev. 2011; 24: 281-295.
5. Rempel OR, Laupland KB,. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect. 2009; 137: 1665-1673.
6. European Centre for Disease Prevention and Control. About EARS-Net. Available at: http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/about-network/Pages/about-network.aspx. Accessed August 27, 2014.
7. European Centre for Disease Prevention and Control. Reporting Protocol, EARS-Net 2013. ECDC: Stockholm, Sweden; 2013.
8. European Centre for Disease Prevention and Control. Reporting Protocol, EARS-Net 2010. ECDC: Stockholm, Sweden; 2010.
9. Diaz Högberg L, Bielicki J, Sharland M, Heuer O, EARS-Net participants. Antimicrobial resistance in invasive Klebsiella pneumoniae isolates: total population-level resistance percentages do not reflect resistance percentages in childhood isolates. 31st ESPID Annual Conference. Milan, Italy; 2013.
10. Wilson J, Elgohari S, Livermore DM, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect. 2011; 17: 451-458.
11. Oteo J, Baquero F, Vindel A, Campos J, et al. Antibiotic resistance in 3113 blood isolates of Staphylococcus aureus in 40 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000-2002). J Antimicrob Chemother. 2004; 53: 1033-1038.
12. Biedenbach DJ, Moet GJ, Jones RN,. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis. 2004; 50: 59-69.
13. Henderson KL, Muller-Pebody B, Johnson AP, Goossens H, Sharland M, Group A. First set-up meeting for antibiotic resistance and prescribing in European Children (ARPEC). Euro Surveill. 2009; 14 (45).
14. Versporten A, Sharland M, Bielicki J, et al; ARPEC Project Group Members. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013; 32: e242-e253.
15. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC: Stockholm, Sweden; 2013.
16. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC: Stockholm, Sweden; 2012.
17. OECD. Health at a Glance 2013: OECD Indicators 2013. Available at: http://dx.doi.org/10.1787/health-glance-2013-en. Accessed July 17, 2014.
18. Hersh AL, Shapiro DJ, Pavia AT, et al. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011; 128: 1053-1061.
19. Shapiro DJ, Hicks LA, Pavia AT, et al. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014; 69: 234-240.
20. Bielicki J, Versporten A, Planche T, Goossens H, Sharland M, ARPEC Project. Gram-negative bacterial bloodstream isolates from neonates and children in 10 European centres: strikingly low quinolone resistance. 23rd ECCMID. Berlin, Germany; 2013.
21. Zarb P, Amadeo B, Muller A, et al; ESAC-3 Hospital Care Subproject Group. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother. 2011; 66: 443-449.
22. Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004; 38: 632-639.
23. Laupland KB, Gregson DB, Vanderkooi OG, et al. The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006. Pediatr Infect Dis J. 2009; 28: 114-117.
24. Ariffin N, Hasan H, Ramli N, et al. Comparison of antimicrobial resistance in neonatal and adult intensive care units in a tertiary teaching hospital. Am J Infect Control. 2012; 40: 572-575.
25. Kuster SP, Ruef C, Zbinden R, et al. Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay. J Antimicrob Chemother. 2008; 62: 1451-1461.
26. Iversen BG, Brantsaeter AB, Aavitsland P,. Nationwide study of invasive Pseudomonas aeruginosa infection in Norway: importance of underlying disease. J Infect. 2008; 57: 139-146.
27. Parkins MD, Gregson DB, Pitout JD, et al. Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection. Infection. 2010; 38: 25-32.
28. Schechner V, Nobre V, Kaye KS, et al. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis. 2009; 48: 580-586.
29. Ladhani S, Pebody RG, Ramsay ME, et al. Continuing impact of infectious diseases on childhood deaths in England and Wales, 2003-2005. Pediatr Infect Dis J. 2010; 29: 310-313.
30. Ladhani SN, Slack MP, Andrews NJ, et al. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis. 2013; 19: 61-68.
31. Le Doare K, Nichols AL, Payne H, et al; CABIN Network. Very low rates of culture-confirmed invasive bacterial infections in a prospective 3-year population-based surveillance in Southwest London. Arch Dis Child. 2014; 99: 526-531.
32. Lenz R, Leal JR, Church DL, et al. The distinct category of healthcare associated bloodstream infections. BMC Infect Dis. 2012; 12: 85.